← Browse by Condition
Medical Condition
platinum sensitive ovarian cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3
NCT06686030 Phase 2
Recruiting
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
Enrollment
150 pts
Location
China
Sponsor
Akeso
NCT07225270 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Enrollment
528 pts
Location
United States, Japan
Sponsor
Genmab
NCT07024784 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Enrollment
377 pts
Location
United States, Israe...
Sponsor
AbbVie